Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Intervention1: CHOLECALCIFEROL: 500 IU OD FOR 2 MONTHS(PRE-OPERATIVELY)
Control Intervention1: NO TREATMENT: NO TREATMENT
Control Intervention2: NO TREATMENT: NO TREATMENT
Sponsors
DR MILIND HOTE
Eligibility
Inclusion criteria
Inclusion criteria: PATIENT WITH CORONARY ARTERY DISEASE ACCEPTED FOR CORONARY ARTERY BYPASS GRAFTING SURGERY
Exclusion criteria
Exclusion criteria: 1.PATIENT WITH DIABETES MELLITUS WITH HbA1c >8.0 2.IMMUNOCOMPROMISED STATUS 3.COLLAGEN VASCULAR DISEASE 4.AUTOIMMUNE DISEASE
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| COMPUTED TOMOGRAPHY SCORE(CT SCORE)Timepoint: 3 MONTHS AFTER CORONARY ARTERY BYPASS GRAFTING SURGERY | — |
Secondary
| Measure | Time frame |
|---|---|
| STERNAL MOBILITY CLINICALLYTimepoint: 1 MONTH AND 3 MONTHS AFTER CORONARY ARTERY BYPASS GRAFTING SURGERY | — |
Countries
India
Contacts
Public ContactDR AFROZA FIRODOUS
AIIMS,NEW DELHI
Outcome results
None listed